Investors & Media

News feed

Ryvu Therapeutics and Selvita Announce registration of Corporate Split by the National Court Register of Poland
01 October 2019

Ryvu Therapeutics and Selvita Announce registration of Corporate Split by the National Court Register of Poland

Continue reading
Selvita announces shareholder approval of corporate split and new name of Ryvu Therapeutics for oncology development company
19 September 2019

Selvita announces shareholder approval of corporate split and new name of Ryvu Therapeutics for oncology development company

Continue reading
Polish Financial Supervision Authority approves Selvita Cro prospectus, allowing corporate split into two separately listed companies to proceed
09 September 2019

Polish Financial Supervision Authority approves Selvita Cro prospectus, allowing corporate split into two separately listed companies to proceed

Continue reading

Shareholder structure

Share in capital
Share in votes
Shareholder Share in capital Share in votes
Paweł Przewięźlikowski
Bogusław Sieczkowski
Augebit FIZ
Nationale Nederlanden OFE
Remaining Management Board and Supervisory Board Members
Remaining Shareholders
* the beneficiary of Augebit FIZ is Tadeusz Wesołowski – Vice Chairman of Selvita Supervisory Board; information based on the number of shares from the last notification provided by the shareholder to the Company (without taking into account the dilution resulting from the issue of H shares).

Reports

selvita_logo

Contacts